Fielmann AG
OTC:FLMNF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Fielmann AG
OTC:FLMNF
|
DE |
|
Dermata Therapeutics Inc
NASDAQ:DRMA
|
US |
|
Deutsche Telekom AG
MIL:DTE
|
DE |
|
PTC Therapeutics Inc
NASDAQ:PTCT
|
US |
|
M
|
McDonald's Corp
SGO:MCD
|
US |
|
Chromadex Corp
NASDAQ:CDXC
|
US |
|
Nestle SA
F:NESR
|
CH |
|
Etteplan Oyj
LSE:0EDL
|
FI |
Wall Street
Price Targets
FLMNF Price Targets Summary
Fielmann AG
According to Wall Street analysts, the average 1-year price target for
FLMNF
is 74.48 USD
with a low forecast of 64.66 USD and a high forecast of 90.06 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is FLMNF's stock price target?
Price Target
74.48
USD
According to Wall Street analysts, the average 1-year price target for
FLMNF
is 74.48 USD
with a low forecast of 64.66 USD and a high forecast of 90.06 USD.
What is Fielmann AG's Revenue forecast?
Projected CAGR
7%
For the last 13 years the
compound annual growth rate for
Fielmann AG's revenue is
6%.
The projected
CAGR
for the next 4 years is
7%.
What is Fielmann AG's Operating Income forecast?
Projected CAGR
14%
For the last 13 years the
compound annual growth rate for
Fielmann AG's operating income is
3%.
The projected
CAGR
for the next 4 years is
14%.
What is Fielmann AG's Net Income forecast?
Projected CAGR
19%
For the last 13 years the
compound annual growth rate for
Fielmann AG's net income is
2%.
The projected
CAGR
for the next 3 years is
19%.
